{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:06:19Z","timestamp":1771949179908,"version":"3.50.1"},"reference-count":7,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In critically ill children, multi-organ-system disease can influence the choice of antiarrhythmic medication. Intravenous therapy is often necessary. There is a scarcity of paediatric critical-care cases demonstrating the dosing, monitoring, and efficacy of intravenous sotalol. This case demonstrates the effective use of intravenous sotalol in an adolescent with renal, hepatic, and haematological dysfunctions.<\/jats:p>","DOI":"10.1017\/s1047951117001408","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T08:35:03Z","timestamp":1502440503000},"page":"1857-1860","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":6,"title":["Intravenous sotalol use in a complex critically ill child: balancing the systems in choosing antiarrhythmic medication"],"prefix":"10.1017","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-2880","authenticated-orcid":false,"given":"Michele M.","family":"Pasierb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Seslar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"S1047951117001408_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90478-2"},{"key":"S1047951117001408_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb00601.x"},{"key":"S1047951117001408_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s002469900104"},{"key":"S1047951117001408_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2016.02.007"},{"key":"S1047951117001408_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90021-4"},{"key":"S1047951117001408_ref2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.63"},{"key":"S1047951117001408_ref3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MJT.0b013e3181ea3184","article-title":"Developing a safe intravenous sotalol dosing regimen","volume":"17","author":"Somberg","year":"2010","journal-title":"Am J Ther"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951117001408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T01:14:38Z","timestamp":1659316478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951117001408\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1047951117001408"],"URL":"https:\/\/doi.org\/10.1017\/s1047951117001408","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]},"assertion":[{"value":"\u00a9 Cambridge University Press 2017\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}